Accuray Extends Availability of CyberKnife Radiosurgery to Cancer Patients in Additional Emerging Markets SUNNYVALE, Calif. , Jan. 17, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that CHRISTUS MUGUERZA Hospital Alta
CyberKnife and TomoTherapy System Growth Driven by Proven Clinical Value and Emerging Replacement Business SUNNYVALE, Calif. , Jan. 10, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today significant momentum in global adoption of its
Data provides new support for efficacy and toxicity benefits of non-invasively delivering High Dose Rate Brachytherapy dosing to patients with prostate cancer SUNNYVALE, Calif. , Jan. 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today
SUNNYVALE, Calif. , Jan. 5, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Needham Growth Conference in New York City on Thursday, January 12, 2012 at 8:40 a.m. EST / 5:40 a.m.
SUNNYVALE, Calif. , Dec. 22, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Euan S. Thomson , Ph.D., is scheduled to present at the J.P.
Provides personalized care to treat the full spectrum of radiation oncology patients SUNNYVALE, Calif. , Dec. 19, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that 23 leading medical centers globally have installed both a
SUNNYVALE, Calif., Dec. 5, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Oppenheimer Healthcare Conference in New York City on Tuesday, December 13, 2011 at 1:00 p.m.
Award Recognizes CyberKnife Benefits for Employees and Employers SUNNYVALE, Calif. , Nov. 30, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that the company received the Outstanding Innovative Improvement Award for its CyberKnife®
SUNNYVALE, Calif. , Nov. 22, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the 23rd Annual Piper Jaffray Healthcare Conference in New York on Wednesday, November 30, 2011 at 12:50 p.m.
SUNNYVALE, Calif., Nov. 10, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Euan S. Thomson , Ph.D., is scheduled to present at the Lazard Capital Markets 8th Annual
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
